Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Pulmonology · Eosinophilic Asthma

What Is Eosinophilic Asthma? Blood Test Results Explained

At a Glance

Eosinophilic asthma is an asthma pattern linked to inflammation involving eosinophils. A high blood eosinophil count can support the assessment and guide treatment, but it cannot diagnose asthma by itself; clinicians also use symptoms, breathing tests, and flare-up history.

If you have asthma and your routine blood work shows “high eosinophils,” it is completely normal to feel concerned. Eosinophils are a type of white blood cell involved in allergic reactions and asthma [1]. However, a high blood eosinophil count alone does not diagnose asthma, nor does it mean your asthma is automatically severe [2]. Instead, it provides your care team with a helpful clue about your asthma phenotype (subtype) [2]. When combined with your symptom history, breathing tests, and exacerbation (flare-up) history, this blood test helps characterize the type of inflammation in your airways and can guide decisions about which treatments might work best for you [3][4].

Urgent Asthma Safety Reminder
This page is for informational purposes and does not replace your personalized asthma action plan. Seek emergency medical care if you experience severe breathlessness, an inability to speak in full sentences, blue or gray lips, confusion, or if your rescue inhaler is not providing relief.

What Are Eosinophils and T2-High Asthma?

Eosinophils are a normal part of your immune system that help fight off certain infections, such as parasites, and play a role in allergic reactions [1].

In a condition known as Type 2 (T2-high) asthma, the immune system’s signaling pathways—specifically involving chemical messengers like IL-4, IL-5, and IL-13—overreact [1]. This process can cause the body to produce too many eosinophils, which can travel to the lungs and contribute to airway swelling, mucus buildup, and hypersensitivity [5].

It is important to know that blood eosinophils are a biomarker (a measurable indicator), not a direct measurement of lung inflammation [2]. You can have T2-high asthma without having high blood eosinophils, and asthma can involve mixed patterns of inflammation [4].

How the Blood Test Works

When you get a standard Complete Blood Count (CBC) with a “differential,” the lab measures the different types of white blood cells. Your doctor looks specifically at the Absolute Eosinophil Count (AEC) [6]. This number is calculated by multiplying your total white blood cell count by the percentage of eosinophils [6].

The definition of a “high” result depends on why the test is being reviewed:

  • In general medicine: General eosinophilia is usually defined as an AEC over 500 cells/µL [6].
  • In asthma care: Doctors often look at lower thresholds, such as 150 cells/µL or 300 cells/µL, to help predict whether a patient with severe asthma might respond to certain targeted therapies [7][3].

Blood eosinophil levels are not static. A single result is imperfect because counts fluctuate based on the time of day, seasonal allergies, or recent infections [8][9].

Additionally, standard asthma controller medications, particularly inhaled corticosteroids (ICS) and oral steroids, genuinely suppress eosinophil levels [10].

Important: Never stop or withhold your controller inhaler to try and get a “more accurate” blood test. Your clinician will interpret your blood results in the context of the medications you are currently taking [10].

What High Eosinophils Mean for Your Treatment

If your evaluation points to an eosinophilic asthma pattern, your doctor will tailor your treatment based on your symptoms, exacerbation history, and current control:

  • Inhaled Corticosteroids: Because Type 2 inflammation generally responds well to steroids, ICS-containing inhalers remain a foundational treatment to reduce airway swelling [10]. Your doctor will first ensure you are using the right dose, that your inhaler technique is correct, and that you are taking it consistently.
  • Biologic Therapies: If your asthma remains severe and uncontrolled despite correct, consistent use of high-dose inhalers, an elevated eosinophil count may support the consideration of a biologic therapy [11]. Biologics are targeted medications (usually given by injection) that block the immune signals (like IL-5 or IL-4/13) involved in T2 inflammation [12][13]. Having an AEC of 150 or 300 cells/µL does not automatically qualify you for a biologic; rather, it is one factor specialists use to select the right drug [11]. In appropriately selected patients, biologics can significantly reduce severe exacerbations, though their effects on day-to-day symptoms and lung function can vary [12][13].

When Doctors Look for Other Causes

An elevated eosinophil count is not specific to asthma. Even slightly or moderately elevated numbers can be caused by other factors, including seasonal allergies, skin conditions, reactions to new medications, or parasitic infections [6][14].

Depending on your clinical picture, your doctor might repeat the test or ask about recent travel to areas where parasites are common, exposure to untreated water, or any new symptoms like unusual rashes or chronic sinus issues [6][15]. A persistently high AEC (such as above 1,500 cells/µL) generally warrants a more deliberate medical evaluation to rule out other underlying hematologic or systemic conditions, but your doctor will investigate any unexpected result based on your overall health [6][16].

What This Test Cannot Tell You

  • It cannot formally diagnose asthma (which requires breathing tests like spirometry).
  • It cannot predict exactly when you might have your next asthma exacerbation.
  • It cannot replace other tests like a fractional exhaled nitric oxide (FeNO) breathing test or allergy testing, which provide different pieces of the T2-inflammation puzzle.

Common questions in this guide

What does eosinophilic asthma mean?
Eosinophilic asthma is an asthma pattern linked to increased eosinophils, a type of white blood cell, and Type 2 immune inflammation. This inflammation can contribute to airway swelling, mucus, and sensitivity, but a high blood count alone does not prove that asthma is present or severe.
Can a blood test by itself diagnose eosinophilic asthma?
No. The absolute eosinophil count can support identification of an eosinophilic pattern, but asthma diagnosis also uses symptoms, breathing tests such as spirometry, and a history of flare-ups.
What eosinophil number is high when someone has asthma?
For general medical use, an absolute eosinophil count above 500 cells/µL is commonly considered high. Asthma clinicians may use 150 or 300 cells/µL as clues when considering response to biologic treatment, but these numbers do not diagnose asthma or automatically qualify someone for a biologic.
Can my asthma medication affect the blood test?
Yes. Inhaled corticosteroids and oral steroids can lower blood eosinophil levels, and counts can also change with time of day, seasonal allergies, or recent infections. Do not stop or skip a controller inhaler to change the result; your clinician will interpret it in the context of your current treatment.
Does a high eosinophil count mean my asthma is severe?
Not necessarily. The count is one clue and must be interpreted with symptoms, breathing tests, medication use, and exacerbation history; it does not predict exactly when the next flare-up will happen.
What can cause high eosinophils besides asthma?
Seasonal allergies, skin conditions, reactions to new medicines, and parasitic infections can raise eosinophils. A clinician may repeat the test and ask about travel, untreated water exposure, rashes, or sinus symptoms; a persistent count above 1,500 cells/µL may need a broader evaluation.
What other tests help identify my asthma pattern?
Spirometry helps diagnose asthma by measuring how air moves through the lungs. FeNO and allergy testing can provide additional information about Type 2 airway inflammation and allergic triggers, so clinicians often consider them alongside symptoms and blood results.

Get notified when new evidence is published on asthma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (16)
  1. 1

    The Therapeutic Potential for Targeting Group 2 Innate Lymphoid Cells in Asthma.

    Matsuyama T, Matsuyama H, Dotake Y, et al.

    Frontiers in immunology 2022; (13()):930862 doi:10.3389/fimmu.2022.930862.

    PMID: 35911708
  2. 2

    Improving the diagnosis of eosinophilic asthma.

    Coumou H, Bel EH

    Expert review of respiratory medicine 2016; (10(10)):1093-103 doi:10.1080/17476348.2017.1236688.

    PMID: 27624868
  3. 3

    Dupilumab Is Effective in Patients With Moderate-to-Severe Uncontrolled GINA-Defined Type 2 Asthma Irrespective of an Allergic Asthma Phenotype.

    Rabe KF, FitzGerald JM, Bateman ED, et al.

    The journal of allergy and clinical immunology. In practice 2022; (10(11)):2916-2924.e4 doi:10.1016/j.jaip.2022.06.036.

    PMID: 36028446
  4. 4

    Diagnostic accuracy of minimally invasive markers for detection of airway eosinophilia in asthma: a systematic review and meta-analysis.

    Korevaar DA, Westerhof GA, Wang J, et al.

    The Lancet. Respiratory medicine 2015; (3(4)):290-300.

    PMID: 25801413
  5. 5

    The Possible Roles of IL-4/IL-13 in the Development of Eosinophil-Predominant Severe Asthma.

    Nakagome K, Nagata M

    Biomolecules 2024; (14(5)) doi:10.3390/biom14050546.

    PMID: 38785953
  6. 6

    Workup for eosinophilia.

    Guo C, Bochner BS

    Allergy and asthma proceedings 2019; (40(6)):429-432 doi:10.2500/aap.2019.40.4264.

    PMID: 31690387
  7. 7

    Biomarkers for severe eosinophilic asthma.

    Yancey SW, Keene ON, Albers FC, et al.

    The Journal of allergy and clinical immunology 2017; (140(6)):1509-1518 doi:10.1016/j.jaci.2017.10.005.

    PMID: 29221581
  8. 8

    Association between fractional exhaled nitric oxide, sputum induction and peripheral blood eosinophil in uncontrolled asthma.

    Gao J, Wu F

    Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2018; (14()):21 doi:10.1186/s13223-018-0248-7.

    PMID: 29796021
  9. 9

    Correlation of FENO With Spirometric Measurements and Blood Eosinophil Level in Patients With Severe Asthma.

    Kwok WC, Ip MSM, Tam TCC, et al.

    The clinical respiratory journal 2025; (19(7)):e70094 doi:10.1111/crj.70094.

    PMID: 40702961
  10. 10

    Impact of an increase in the inhaled corticosteroid dose on blood eosinophils in asthma.

    Lommatzsch M, Klein M, Stoll P, Virchow JC

    Thorax 2019; (74(4)):417-418 doi:10.1136/thoraxjnl-2018-212233.

    PMID: 30315084
  11. 11

    Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline.

    Holguin F, Cardet JC, Chung KF, et al.

    The European respiratory journal 2020; (55(1)) doi:10.1183/13993003.00588-2019.

    PMID: 31558662
  12. 12

    Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies.

    Ortega HG, Yancey SW, Mayer B, et al.

    The Lancet. Respiratory medicine 2016; (4(7)):549-556 doi:10.1016/S2213-2600(16)30031-5.

    PMID: 27177493
  13. 13

    Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma.

    Castro M, Corren J, Pavord ID, et al.

    The New England journal of medicine 2018; (378(26)):2486-2496 doi:10.1056/NEJMoa1804092.

    PMID: 29782217
  14. 14

    Hypereosinophilia: Biological investigations and etiologies in a French metropolitan university hospital, and proposed approach for diagnostic evaluation.

    Peju M, Deroux A, Pelloux H, et al.

    PloS one 2018; (13(9)):e0204468 doi:10.1371/journal.pone.0204468.

    PMID: 30256812
  15. 15

    [The evaluation of a patient with eosinophilia].

    van Gils LAJ, Remmelts HHF, Fijnheer R, et al.

    Nederlands tijdschrift voor geneeskunde 2024; (168()).

    PMID: 39714821
  16. 16

    World Health Organization-defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management.

    Shomali W, Gotlib J

    American journal of hematology 2019; (94(10)):1149-1167 doi:10.1002/ajh.25617.

    PMID: 31423623

This page is for informational purposes only and does not constitute medical advice or replace your asthma action plan. Ask your clinician to interpret your eosinophil results, and seek emergency care for severe breathing symptoms.